medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2016, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2016; 32 (2)

Red blood cell antigens and antibodies in patients awaiting renal transplantation

Bencomo HAA, Aquino RS, González DI, Chang MA, Morera BLM, Rodríguez LR

Language: Spanish
References: 31
Page: 223-235
PDF size: 161.52 Kb.


ABSTRACT

Introduction: The importance of blood groups in transfusion therapy and transplant is very well known. The presence of red blood cell antibodies can mediate severe hemolytic transfusion reactions and transplant rejection.
Objective: To characterize red blood cell antigens and antibodies in patients awaiting renal transplantation.
Methods: A prospective study in 980 patients in waiting list for renal transplantation in the period from July, 2013 to July, 2014 was carried out. The frequency of ABO, Rh (DCcEe), Kell (K), Duffy, Kidd and Lewis blood groups, and the screening of red blood cells auto and alloantibodies by the direct and indirect antiglobulin test (Coombs) and the polietilenglicol technique were investigated.
Results: Blood group O was the most frequent followed by A, B and AB. DCCee phenotype was frequent in white individuals and Dccee in non-white. RhD negative (ccee) was more frequent in whites than in non-whites. Distribution of Kell antigen was similar in both groups. Direct antiglobulin test was positive In 14 patients (1,4 %) and red blood cell alloantibodies were identified in 35 patients for a frequency of alloimmunization of 3,6 %. Anti-Rh anti-K antibodies were the alloantibodies most frequently identified. The polietilenglicol technique detected a higher number of antibodies than the indirect antiglobulin test, specially against RhD antigen, although the comparison was not statistically significant.
Conclusions: The frequency of alloimmunization is smaller than those communicated in other studies which was related to transfusion records. A periodic red blood cell auto and alloantibodies screening is recommended in all patients awaiting renal transplantation.


REFERENCES

  1. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007 Jan, 21; 1: 58-71.

  2. Tinegate H, Birchall J, Gray A, Haggas R, Massey R,Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions prepared by the BCSH blood transfusion task force. Br J Haematol. 2012 Aug; 159:143-53.

  3. Hod EA, Sokol SA, Zimring JC, et al. Hypothesis: Hemolytic transfusion reactions represent an alternative type of anaphylaxis. Int J Clin Exp Pathol. 2009; 2:71-82.

  4. Ballester JM, Alfonso ME, Ballester L, Bencomo AA, Cortina L, Macías C, et al. Procederes de bancos de sangre y servicios de transfusiones. La Habana: Instituto de Hematología e Inmunología, Organización Panamericana de la Salud; 2004.

  5. Brecher ME, ed. Technical Manual. 16th ed. Bethesda, MD American Association of Blood Banks; 2008. p. 241-82.

  6. Poole J. What methods and process flow can assist in alloantibody identification? ISBT Sci Series. 2012; 7, 58-61.

  7. Lerut E, Van Damme B, Noizat-Pirenne F, Emonds MP, Rouger P, Vanrenterghem Y, et al. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion 2007 May ;47:28-40.

  8. Rourk A, Squires JE. Implications of the Kidd blood group system in renal transplantation. Immunohematology. 2012;28(3):90-4.

  9. Watorek E, Boratyńska M, Hałoń A, Klinger M. Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient. Ann Transplant. 2008; 13(1):48-52.

  10. Shanthi B, Sreebhushan Raju D, Dasarath D, Sandip VS. Anti-Leb (Lewis) antibody in renal transplantation, emphasizing the role of transfusion medicine in organ transplantation. Asian J Transfus Sci. 2012 Jan-Jun; 6(1): 53-54.

  11. Bencomo AA, Alfonso ME, Alfonso Y, Díaz M. Procedimientos para La detección e identificación de anticuerpos eritrocitarios. Prueba de compatibilidad pretransfusional. En: Suardíaz, J, Cruz C, Colina A. Laboratorio Clínico. La Habana: Ciencias Médicas; 2004:575-92.

  12. World Medical Association (AMM). Helsinki Declaration. Ethical principles for medical research involving human subjects. Assist Inferm Ric. 2001 Apr- Jun;20(2):104-7.

  13. World Medical Association. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.

  14. Nankivell BJ,Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2010 Oct;363 (15):1451-62.

  15. Bencomo AA, Alfonso ME, Alfonso Y, Díaz M. Grupos sanguíneos eritrocitarios. En: Suardíaz, J, Cruz C, Colina A. Laboratorio Clínico. La Habana: Ciencias Médicas; 2004: 553-74.

  16. Westhoff CM, Shaz BH. ABO and H blood group system. En: Shaz BH, Hillyer CD, Roshal M, Abrams CH. Transfusion medicine and hemostasis. Clinical and laboratory aspects. Second edition. London: Elsevier Inc; 2013: 149-56.

  17. Westhoff CM, Shaz BH. Rh and RhAG blood group systems. En: Shaz BH, Hillyer CD, Roshal M, Abrams CH. Transfusion medicine and hemostasis. Clinical and laboratory aspects. Second edition. London: Elsevier Inc; 2013: 157-62.

  18. Combs MR. Lewis blood group system review. Immunohematology. 2009; 25(3): 112-18.

  19. Meny GM. The Duffy blood group system: a review. Immunohematology. 2010; 26(2): 51-6.

  20. Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in african americans. Transplantation. 2003; 75:1496-500.

  21. Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol. 2013 Oct;13(10):738-53.

  22. Rodríguez-Iturbe B, Pons H, Quiroz Y, Lanaspa MA, Johnson RJ. Autoimmunity in the pathogenesis of hypertension. Nat Rev Nephrol. 2014 Jan;10(1):56-62.

  23. Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol. 2011; 4(6), 607-18.

  24. Ochoa M, Basanta P, Bencomo A. Aloinmunización antieritrocitaria en pacientes politransfundidos con insuficiencia renal. Rev Cubana Hematol Inmunol Hemoter, 1992, 28(4): 253-255.

  25. Fernandes Ribeiro da Silva S, Ferreira GM, Leite da Silva S, de Oliveira Alves TM, Farias Ribeiro I, Rodrigues Ribeiro T. Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation. Rev Bras Hematol Hemoter. 2013; 35(3):185-8.

  26. Pérez Oliva JF, Lagarde AM, Herrera Valdés R, Martínez AI, Raola ME, Magrans C. Broad use of Cuban recombinant human erythropoietin (IOR-EPOCIM) in dialysis patients at the Institute of Nephrology. MEDICC Rev. 2005 May; 7(5):11-4.

  27. Tanhehco YC, Berns J S. Red blood cell transfusion risks in patients with endstage renal disease. Sem Dialysis. 2012 Sep-Oct; 25 (5): 539-44.

  28. Zalpuri S, Zwaginga JJ, le Cessie S, et al. Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang. 2012; 102:144-9.

  29. Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens in a caucasian population, based on HLA class II restriction analysis. Transfusion 2006; 46:1328-33.

  30. Chou ST, Liem RI, Thompson AA. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol. 2012 Oct; 159: 394-404.

  31. Schonewille H, Doxiadis IN, Levering WHBM, Roelen DL, Claas FHJ, Brand A. HLADRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion. 2014 Aug; 54:1971-80.




2020     |     www.medigraphic.com